Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 149 (3), 464-473
- https://doi.org/10.1016/j.ahj.2004.11.023
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemiaThe American Journal of Cardiology, 2004
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine, 2004
- Population implications of changes in lipid management in patients with coronary heart disease.The American Journal of Cardiology, 2004
- Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive proteinThe American Journal of Cardiology, 2003
- Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemiaJournal of the American College of Cardiology, 2002
- Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemiaThe American Journal of Cardiology, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- A sharper Bonferroni procedure for multiple tests of significanceBiometrika, 1988